Alnylam Pharmaceuticals, Inc. (ALNY) Stock Prediction 2026

Alnylam Pharmaceuticals, Inc. is scored daily by TradeWell’s model ensemble. The TW Quant Score below is the model’s conviction percentile among 4,149 scored stocks on the 1Y horizon — one of 10 horizons (1D to 5Y) scored for every covered stock.

2
TW Quant Score (1Y) · Healthcare · Biotechnology
Last price $149.76 · as of November 19, 2026

TW Quant Score is research, not investment advice. It is not a recommendation to buy or sell any security. Predictions can be wrong. Past model performance does not guarantee future results.

As of November 19, 2026, Alnylam Pharmaceuticals, Inc. ranks #4,082 of 4,149 scored stocks on the 1Y horizon.

Signal breakdown — as of November 19, 2026

Each signal is scored 0–100. A dash means the signal was not computed for ALNY on this scan — TradeWell discloses missing data rather than printing a fake zero.

Trend20
Momentum23
Volume0
Pattern30
Insider activity90
News sentiment50
Seasonality68
Macro / sector50
Mean reversion68
Fundamental86

Expected return and price target

Model expected returns and model-implied price targets for Alnylam Pharmaceuticals, Inc. across all 10 horizons are published in the app and refreshed daily. They are not reproduced on this page.

See the live ALNY forecast →

How this prediction is built

A multi-model ensemble (Ridge, XGBoost, LightGBM, and deeper research models) ranks 4,000+ stocks daily per horizon; predictions are tracked and graded against real outcomes. Method details: methodology. All prediction pages: index.